森萱医药
(830946)
| 流通市值：54.33亿 | | | 总市值：54.35亿 |
| 流通股本：4.27亿 | | | 总股本：4.27亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 657,357,000.25 | 533,026,389.27 | 513,461,081.25 | 505,949,141.18 |
| 应收票据及应收账款 | 57,690,012.98 | 70,672,389.55 | 54,577,450.05 | 50,087,944.54 |
| 其中：应收票据 | 11,187,769.67 | 9,967,464.58 | 12,445,906.51 | 15,850,023.4 |
| 应收账款 | 46,502,243.31 | 60,704,924.97 | 42,131,543.54 | 34,237,921.14 |
| 应收款项融资 | 31,877,699.06 | 34,523,046.38 | 37,911,622.12 | 29,954,234.19 |
| 预付款项 | 3,343,230.46 | 3,848,294.64 | 5,637,160.66 | 6,992,289.11 |
| 其他应收款合计 | 286,412.72 | 247,904.33 | 217,305.92 | 210,301.63 |
| 存货 | 140,476,004.39 | 143,082,137.18 | 146,378,353.94 | 145,993,690.74 |
| 一年内到期的非流动资产 | - | 46,451,166.65 | 45,283,333.32 | 44,115,500 |
| 其他流动资产 | 117,013.51 | 32,197.51 | 2,977.67 | 99,006.31 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 931,459,373.37 | 912,009,914.4 | 940,739,010.96 | 919,659,863.87 |
| 非流动资产: | | | | |
| 固定资产 | 320,782,243.59 | 331,132,047.5 | 341,639,869.66 | 352,114,874.54 |
| 在建工程 | 27,121,420.39 | 26,779,321.27 | 23,454,152.42 | 9,854,529.85 |
| 使用权资产 | 1,960,593.54 | 2,390,686.29 | 2,820,779.03 | 2,815,369.65 |
| 无形资产 | 35,918,990.46 | 36,217,803.37 | 36,519,049.9 | 36,821,513.26 |
| 递延所得税资产 | 6,078,068.46 | 5,748,288.62 | 5,403,383.1 | 5,032,549.92 |
| 其他非流动资产 | - | - | - | 1,014,595 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 391,861,316.44 | 402,268,147.05 | 409,837,234.11 | 407,653,432.22 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,323,320,689.81 | 1,314,278,061.45 | 1,350,576,245.07 | 1,327,313,296.09 |
| 流动负债: | | | | |
| 短期借款 | 4,005,666.71 | 15,016,666.71 | 20,023,541.7 | 20,023,541.69 |
| 应付票据及应付账款 | 33,105,835.01 | 32,844,482.81 | 33,873,286.51 | 38,965,566.47 |
| 其中：应付票据 | - | - | 1,537,865.6 | 3,382,136.54 |
| 应付账款 | 33,105,835.01 | 32,844,482.81 | 32,335,420.91 | 35,583,429.93 |
| 合同负债 | 3,526,428.65 | 3,236,947.51 | 4,780,720.49 | 5,067,012.82 |
| 应付职工薪酬 | 20,540,407.79 | 17,434,875.7 | 15,335,865.17 | 23,536,847.71 |
| 应交税费 | 6,717,595.92 | 10,091,333.32 | 8,007,033.69 | 7,476,861.55 |
| 其他应付款合计 | 6,911,255.12 | 8,795,457.54 | 6,371,071.37 | 5,994,679.17 |
| 应付股利 | - | 2,000,000 | - | - |
| 一年内到期的非流动负债 | 1,618,016.88 | 1,628,624.32 | 1,742,302.56 | 1,488,187.23 |
| 其他流动负债 | 5,524,016.18 | 6,159,646.38 | 5,441,586.46 | 6,957,055.42 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 81,949,222.26 | 95,208,034.29 | 95,575,407.95 | 109,509,752.06 |
| 非流动负债: | | | | |
| 租赁负债 | 83,913.54 | 825,199.82 | 947,696.71 | 1,014,879.98 |
| 递延收益 | 2,345,477.92 | 2,418,897.04 | 2,182,941.16 | 2,228,235.28 |
| 递延所得税负债 | 4,902,446.58 | 4,642,288.64 | 5,199,271.53 | 4,982,573.8 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 7,331,838.04 | 7,886,385.5 | 8,329,909.4 | 8,225,689.06 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 89,281,060.3 | 103,094,419.79 | 103,905,317.35 | 117,735,441.12 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 426,918,340 | 426,918,340 | 426,918,340 | 426,918,340 |
| 资本公积 | 217,559,039.68 | 217,559,039.68 | 217,559,039.68 | 217,559,039.68 |
| 专项储备 | 2,545,989.41 | 2,469,831.44 | 2,179,039.66 | 1,506,441.88 |
| 盈余公积 | 42,041,795.43 | 42,041,795.43 | 42,041,795.43 | 42,041,795.43 |
| 未分配利润 | 471,032,142.57 | 449,346,064.06 | 482,834,146.66 | 447,972,391.44 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,160,097,307.09 | 1,138,335,070.61 | 1,171,532,361.43 | 1,135,998,008.43 |
| 少数股东权益 | 73,942,322.42 | 72,848,571.05 | 75,138,566.29 | 73,579,846.54 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,234,039,629.51 | 1,211,183,641.66 | 1,246,670,927.72 | 1,209,577,854.97 |
| 负债和股东权益合计 | 1,323,320,689.81 | 1,314,278,061.45 | 1,350,576,245.07 | 1,327,313,296.09 |
| 公告日期 | 2024-10-29 | 2024-08-27 | 2024-04-29 | 2024-04-18 |
| 审计意见(境内) | | | | 标准无保留意见 |